Revenue: The sum of all revenue fields included for a company's operating activities.
Kura Oncology, Inc. (KURA) had Revenue of $53.88M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$53.88M |
$-173.98M |
|
-- |
|
$53.88M |
|
$247.08M |
|
$-193.19M |
|
$21.23M |
|
$-171.97M |
|
$-171.97M |
|
$-173.98M |
|
$-173.98M |
|
$-173.98M |
|
$-173.98M |
|
$-193.19M |
|
$-205.49M |
|
86.16M |
|
86.16M |
|
$-2.02 |
|
$-2.02 |
|
| Balance Sheet Financials | |
$744.83M |
|
$1.68M |
|
$15.33M |
|
$760.16M |
|
$78.71M |
|
$6.92M |
|
$267.81M |
|
$346.52M |
|
$413.64M |
|
$413.64M |
|
$413.64M |
|
78.23M |
|
| Cash Flow Statement Financials | |
$134.32M |
|
$-101.59M |
|
$154.42M |
|
$37.32M |
|
$224.46M |
|
$187.14M |
|
$33.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.46 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
100.00% |
|
-358.55% |
|
-358.55% |
|
-381.36% |
|
-319.15% |
|
-322.89% |
|
$133.84M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-42.06% |
|
-42.06% |
|
-22.89% |
|
-41.37% |
|
$5.29 |
|
$1.55 |
|
$1.56 |
|